Clinical Trial Update: Efficacy Study of Quetiapine Plus Topiramate for Reducing Cannabis Consumption and Bipolar Mania [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating quetiapine plus topiramate for reducing cannabis use and managing bipolar mania has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Cannabis-related Disorder

Drugs mentioned

• Quetiapine (quetiapine)
• Topiramate (Topiramate)

Snippet

Sponsor: University of Cincinnati | Conditions: Bipolar Disorder, Cannabis-Related Disorder | Phase 4 | Status: COMPLETED | Results posted: 2017-08-29